Stock Information

Copyright West LLC. Minimum 15 minutes delayed.

Investor Relations

News Releases

21 Jan '2020
PRINCETON, N.J. , Jan. 21, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS) (the “Company”) , a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced it has entered into a definitive agreement with two institutional